It's time to get serious about the economics of expanded access - STAT

It's time to get serious about the economics of expanded access - STAT

It’s time to get serious about the economics of expanded access

By PETER J. PITTS

ADOBE

If drug companies have an obligation to consider expanded access, do payers too? It's time for the discussion about expanded access to get serious.

READ MORE